Cyclacel Pharmaceuticals, Inc. - Common Stock (NQ:CYCC)

6.365 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 11, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cyclacel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 08, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 08, 2024

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

Via InvestorPlace

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

Earnings Outlook For Cyclacel Pharmaceuticals ↗

November 10, 2023

Via Benzinga

Cyclacel Pharmaceuticals's Earnings Outlook ↗

August 08, 2023

Via Benzinga

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024

January 02, 2024

From Cyclacel

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 22, 2023

Via Benzinga

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 22, 2023

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Via Benzinga

Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In November ↗

December 22, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 37,458.12 while the NASDAQ rose...

Via Benzinga

Topics Economy Stocks

Why Cyclacel Pharmaceuticals (CYCC) Shares Are Getting Obliterated ↗

December 22, 2023

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares are trading lower by 26.9% to $2.63 Friday morning after the company announced it finalized an agreement to sell 388,200 shares of its common stock at...

Via Benzinga

Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules

December 22, 2023

From Cyclacel

Via GlobeNewswire

CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q1 2023 ↗

December 20, 2023

CYCC stock results show that Cyclacel Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2023.

Via InvestorPlace

CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q2 2023 ↗

December 20, 2023

CYCC stock results show that Cyclacel Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2023.

Via InvestorPlace

CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q3 2023 ↗

December 20, 2023

CYCC stock results show that Cyclacel Pharmaceuticals missed analyst estimates for earnings per share the third quarter of 2023.

Via InvestorPlace

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions

December 18, 2023

From Cyclacel

Via GlobeNewswire

Cyclacel Pharmaceuticals Announces Reverse Stock Split

December 12, 2023

From Cyclacel

Via GlobeNewswire

Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC

November 30, 2023

From Cyclacel

Via GlobeNewswire

Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

November 30, 2023

Shares of Salesforce, Inc.

Via Benzinga

Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q

November 28, 2023

From Cyclacel

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 28, 2023

It's time to dive into the biggest pre-market stock movers for Tuesday morning with all of the latest news you need to know today!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 24, 2023

Via Benzinga

Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 22, 2023

Shares of Guess?, Inc. (NYSE: GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance...

Via Benzinga

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

November 13, 2023

From Cyclacel

Via GlobeNewswire

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results

November 07, 2023

From Cyclacel

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 18, 2023

Via Benzinga

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

August 09, 2023

From Cyclacel

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.